Financhill
Sell
46

PHR Quote, Financials, Valuation and Earnings

Last price:
$19.83
Seasonality move :
17.31%
Day range:
$20.21 - $20.93
52-week range:
$18.55 - $32.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.67x
P/B ratio:
4.08x
Volume:
1000K
Avg. volume:
700.9K
1-year change:
-3.98%
Market cap:
$1.2B
Revenue:
$419.8M
EPS (TTM):
-$0.41

Analysts' Opinion

  • Consensus Rating
    Phreesia, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $33.69, Phreesia, Inc. has an estimated upside of 66.03% from its current price of $20.29.
  • Price Target Downside
    According to analysts, the lowest downside price target is $30.00 representing 100% downside risk from its current price of $20.29.

Fair Value

  • According to the consensus of 12 analysts, Phreesia, Inc. has 66.03% upside to fair value with a price target of $33.69 per share.

PHR vs. S&P 500

  • Over the past 5 trading days, Phreesia, Inc. has underperformed the S&P 500 by -1.28% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Phreesia, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Phreesia, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Phreesia, Inc. reported revenues of $117.3M.

Earnings Growth

  • Phreesia, Inc. has grown year-over-year earnings for 11 quarters straight. In the most recent quarter Phreesia, Inc. reported earnings per share of $0.01.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
2.67x
EV / EBIT:
--
EV / Revenue:
2.51x
PEG ratio (5yr expected):
--
EV / Free cash flow:
40.58x
Price / Operating cash flow:
43.12x
Enterprise value / EBITDA:
302.92x
Gross Profit (TTM):
$275.9M
Return On Assets:
-6.21%
Net Income Margin (TTM):
-5.35%
Return On Equity:
-8.9%
Return On Invested Capital:
-8.38%
Operating Margin:
-1.29%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-07-31 2024-07-31 2025-07-31 2024-07-31 2025-07-31
Income Statement
Revenue $319.4M $390M $449.7M $102.1M $117.3M
Gross Profit $172.9M $229.9M $275.9M $61.8M $72M
Operating Income -$154.5M -$95.9M -$26.2M -$17.2M -$1.5M
EBITDA -$124.6M -$65.3M $3.7M -$9.7M $6.1M
Diluted EPS -$2.87 -$1.80 -$0.41 -$0.31 $0.01
Period Ending 2021-07-31 2022-07-31 2023-07-31 2024-07-31 2025-07-31
Balance Sheet
Current Assets $491.9M $315.1M $218.4M $180.1M $222.2M
Total Assets $551.2M $426M $340.4M $362.2M $408.6M
Current Liabilities $57.7M $71.9M $84.9M $102M $105.1M
Total Liabilities $64.7M $77.5M $93.4M $110.9M $110.6M
Total Equity $486.6M $348.5M $247M $251.3M $298M
Total Debt $12.6M $11.3M $15.4M $15.5M $11.9M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-07-31 2024-07-31 2025-07-31 2024-07-31 2025-07-31
Cash Flow Statement
Cash Flow Operations -$60.3M $1.1M $51.7M $11.1M $14.8M
Cash From Investing -$29.1M -$36.7M -$23.8M -$7.4M -$5.2M
Cash From Financing -$23.6M -$10.2M -$11.2M -$1.4M -$2.1M
Free Cash Flow -$85.5M -$25M $27.9M $3.7M $9.6M
PHR
Sector
Market Cap
$1.2B
$28.5M
Price % of 52-Week High
61.94%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-0.15%
-1.33%
1-Year Price Total Return
-3.98%
-20.32%
Beta (5-Year)
0.643
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $20.38
200-day SMA
Sell
Level $25.29
Bollinger Bands (100)
Sell
Level 21.48 - 27.88
Chaikin Money Flow
Buy
Level 15.5M
20-day SMA
Sell
Level $20.83
Relative Strength Index (RSI14)
Sell
Level 40.29
ADX Line
Sell
Level 25.21
Williams %R
Neutral
Level -45.9627
50-day SMA
Sell
Level $22.15
MACD (12, 26)
Sell
Level -0.65
25-day Aroon Oscillator
Sell
Level -52
On Balance Volume
Neutral
Level 32.9M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (6.1055)
Buy
CA Score (Annual)
Level (0.1411)
Buy
Beneish M-Score (Annual)
Level (-3.4373)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.117)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Stock Forecast FAQ

In the current month, PHR has received 12 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PHR average analyst price target in the past 3 months is $33.69.

  • Where Will Phreesia, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Phreesia, Inc. share price will rise to $33.69 per share over the next 12 months.

  • What Do Analysts Say About Phreesia, Inc.?

    Analysts are divided on their view about Phreesia, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Phreesia, Inc. is a Sell and believe this share price will drop from its current level to $30.00.

  • What Is Phreesia, Inc.'s Price Target?

    The price target for Phreesia, Inc. over the next 1-year time period is forecast to be $33.69 according to 12 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is PHR A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Phreesia, Inc. is a Buy. 12 of 12 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of PHR?

    You can purchase shares of Phreesia, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Phreesia, Inc. shares.

  • What Is The Phreesia, Inc. Share Price Today?

    Phreesia, Inc. was last trading at $19.83 per share. This represents the most recent stock quote for Phreesia, Inc.. Yesterday, Phreesia, Inc. closed at $20.29 per share.

  • How To Buy Phreesia, Inc. Stock Online?

    In order to purchase Phreesia, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 69.21% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 8.5% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 6.05% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock